HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Prognostic value of big endothelin-1 prognostic value in patients with heart failure and moderately symptomatic functional class].

AbstractBACKGROUND AND OBJECTIVE:
Several studies have analyzed big endothelin-1 as a marker of mortality in patients with severe heart failure (HF). However, it has not proven prognostic value in patients with moderately symptomatic functional class. Our objective was to evaluate, in a 24 months follow-up, the prognostic power of big endothelin-1 in patients with HF and moderately deteriorated functional class.
MATERIAL AND METHOD:
Big endothelin-1 levels were measured in a cohort of 90 outpatients (age 64 (13), 70% males) diagnosed with HF. Patients were functionally classified (NYHA).
RESULTS:
For the whole population, big endothelin-1 was 0.86 (0.61-1.20)fmol/ml. We evaluated its predictive value in detecting cardiovascular mortality, obtaining an AUC of 0.68 (0.08) (P=.02), and a cut-off value of 0.98 fmol/ml (sensitivity 69%, specificity 75%). When a logistic regression analysis was performed, big endothelin-1 was also an independent predictor of mortality (OR=5.851, P=.009).
CONCLUSIONS:
Big endothelin-1 predicts cardiovascular mortality in patients diagnosed of HF and moderately symptomatic functional class.
AuthorsEsther Roselló-Lletí, Miguel Rivera, Vicente Miró, Raquel Cortés, Luís Martínez-Dolz, Manuel Portolés
JournalMedicina clinica (Med Clin (Barc)) Vol. 133 Issue 5 Pg. 173-6 (Jul 04 2009) ISSN: 0025-7753 [Print] Spain
Vernacular TitleValor pronóstico de big endotelina-1 en pacientes con insuficiencia cardíaca y clase funcional moderadamente sintomática.
PMID19376546 (Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Endothelin-1
Topics
  • Endothelin-1 (blood)
  • Female
  • Follow-Up Studies
  • Heart Failure (blood, classification, mortality, physiopathology)
  • Humans
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Prognosis
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: